The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...

Stanford University scientists have now presented another unique method using a common skin bacterium, Staphylococcus ...

Emerging infectious diseases necessitate rapid production of raw materials for vaccines. Strengthening domestic production and a resilient supply chain are key; advanced manufacturing facilities, like ...

Vaccines have advanced the field of health and medicine throughout the last century. They are commonly given before a disease ...

Scientists' findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions including fever, swelling and pain.

HT interviews winners Professor Raghavan Varadarajan from IISc, Bangalore, and Professor C Anandharamakrishnan, director of CSIR-NIIST ...

Long Covid, a group of Italian researchers have discovered the cause of lung disorders in patients suffering from this ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination.

MEDLEMSNYHET - Approximately 60-70% of infectious diseases are viral, including COVID-19, influenza, MPXV, HIV, and Ebola. These viruses continue to affect human health and socio-economic development.

Imagine a world in which a vaccine is a cream you rub onto your skin instead of a needle a health care worker pushes into your one of your muscles.